Chinese researchers have engineered a novel probiotic that could simplify diabetes care, allowing patients to manage the condition as easily as drinking a cup of yogurt or swallowing a capsule. The team aims to bring the product to the U.S. market within two years.
Also Read
- Spotify Authorizes $1.5 Billion Expansion of Share Buyback Program
- Navigating Mortgage REIT Opportunities Amid Treasury Buying and Rate Shifts
- Eisenkot leaps ahead as Likud support falters, projected to win 26 Knesset seats – poll
- NurExone Secures C$1.07 Million Through Private Placement to Advance Exosome Therapy Development
